Business review Synthomer plc Annual report 2012 13 Financial review Income statement Special items and IFRS The acquisition of PolymerLatex in March 2011 substantially changed The Group reports its financial results according to International Financial the size of the Group.
To allow a meaningful comparison of the results Reporting Standards IFRS.
However, to provide a clearer indication of the for 2012 with 2011, the table below shows pro-forma results by adjusting Groups underlying performance, a number of special items are split out the underlying performance of the Group in 2011 to include results of and shown in a separate column of the consolidated income statement PolymerLatex for Q1 2011, and to allow for an estimated interest cost of due to their one-off or non-economic nature, and are excluded from the 2.1 million for that quarter.
The underlying pro-forma results provided comments on underlying performance above and throughout the Chief the most meaningful comparison of year-on-year performance.
Executives review of business performance.
Special items comprise: s Restructuring costs associated with delivering the synergy targets for Pro-forma results 2012 2011 the PolymerLatex acquisition of 6.7 million 6.0 million cash costs and Underlying Underlying PolymerLatex Pro-forma 0.7 million non-cash costs.
At the time of the acquisition the Group Q1 2011 announced an estimated total cash expenditure of approximately m m m m 20 million to deliver these synergies.
Cash costs of 15.8 million Group were expensed in 2011 together with 4.4 million of non-cash costs.
1,111.8 1,116.8152.01,268.8 Sales s Various cross-currency and interest rate swaps for hedging purposes, 109.0 96.413.3109.7 Operating profit which involve maturities of up to five years.
IFRS requires that where the profit before tax 98.1 84.811.296.0 strict requirements of IAS39 are not met, changes in the market value should be recognised annually in the income statement.
However, such Europe & financial instruments are maintained by the Group for the length of the North America contract and over their lifetime have a fair value of nil.
Hence the notional 796.9 777.7135.3913.0 Sales annual adjustment, a loss of 1.7 million 2011 loss 3.3 million is Operating profit 98.0 73.112.485.5 segregated from the underlying performance.
Asia & ROW s Amortisation of intangibles of 27.4 million comprising 25.8 million in 314.9 339.116.7355.8 Sales the Company and subsidiaries and 1.6 million in share of joint ventures.
Operating profit 19.1 32.10.933.0 IFRS acquisition accounting requires an explicit number to be placed Unallocated on certain intangibles and amortised through the consolidated income Operating profit 8.1 8.8 8.8 statement, with the balance of the excess of the purchase price over the physical assets being carried as goodwill, which is subject to annual impairment testing.
The amortisation expense arising from this has been Sales, operating profit and profit before tax treated as a special item and will continue to be so as the associated underlying non pro-forma intangible assets are fully amortised.
Total sales decreased by 0.4% to 1,111.8 million, with underlying volume s Tax credits of 17.3 million, of which 8.6 million was in respect of the declines and currency translation effects, broadly offset by the benefit of release of notional deferred tax associated with the amortisation of one extra full quarter of turnover from the PolymerLatex acquisition in the acquired intangibles and 1.6 million represented the tax relief from year.
Group operating profit increased by 13%, mainly due to the extra restructuring and site closure costs.
Additionally, a deferred tax asset quarters profit from the PolymerLatex acquisition, whilst profit before tax of 7.1 million was recognised for the UK and has been included in increased by 16% to 98.1 million on an underlying non pro-forma basis.
Tax and EPS underlying non pro-forma Balance sheet The Groups underlying tax rate of 22% 2011 23%, remains low, reecting Goodwill decreased to 240.9 million at the end of 2012 from 244.7 million the benets of pioneer status extended tax holiday on our nitrile business at the end of 2011 due to translation.
in Malaysia, and a zero rate in the UK.
The Group does not expect to pay tax in the UK for the foreseeable future due to brought forward losses and Acquired intangible assets which arose as a result of the PolymerLatex deficit contributions to the UK pension scheme, which are tax deductible.
acquisition decreased to 135.6 million at 31 December 2012 from 165.4 million in the prior year.
This movement reects regular annual profit attributable to minority interests was 1.8 million 2011 1.6 million.
amortisation of 25.8 million reported in special items, and currency translation.
As a result, overall, the underlying earnings per share for 2012 was 22.0p, compared to 18.8p per share for 2011.
This is an increase in underlying Property, plant and equipment increased to 199.6 million at earnings per share of 17%.
31 December 2012 compared to 183.6 million at 31 December 2011.
Additions during the year comprised 40.3 million of capital expenditure Dividend net 38.1 million.
The Group committed to a full year dividend of 5.5p for 2012, at the time of the interim announcement with an interim dividend of 2.2p.
A final dividend The net deferred tax liability has decreased to 40.7 million from of 3.3p per share is therefore recommended, payable on 5 July 2013 to 61.4 million during the year.
The decrease is primarily due to the shareholders on the register on 7 June 2013.
The total dividend of 5.5p recognition of a deferred tax asset of 7.1 million in the UK, the benefit of represents an increase of 57% over 2011. which was reported in special items, and 8.6 million of notional deferred tax associated with acquired intangibles, reported in special items.
14 Synthomer plc Annual report 2012 Financial review continued Pensions Underlying net borrowings reduced during the year to 155.8 million.
In the main UK dened benefit pension scheme the majority of investments are in equities.
All asset classes performed well over the course of 2012, Group management EBITDA increased to 127.4 million reecting the effect with a total return on assets excluding cash of 14.1%.
The yield on of a full year ownership of PolymerLatex 2011 nine months from 1 April.
high-quality corporate bonds decreased slightly during the year, which increased liabilities.
The Company made cash contributions to the fund Net capital expenditure increased substantially in 2012 to 38.1 million in the year of 18.8 million, of which 10 million is a prepayment of 2013 net 40.3 million gross, due to organic expansion in Malaysia and spend contributions.
The overall effect of these changes was that there was a to facilitate the delivery of the acquisition synergies.
small decrease in the deficit of the scheme, which stood at 69.5 million at the end of 2012 2011 73.9 million.
Pension funding in excess of IAS19 charge of 17.3 million includes a 10 million prepayment to the UK pension fund.
This will result in lower An actuarial valuation for 2012 will be nalised by mid 2013.
Due to the cash contributions in 2013. prepayment, cash contributions in 2013 are expected to be of the order of 5 million.
Underlying working capital outow for the year was 1.3 million.
The UK scheme was closed to future accrual during 2009 and there are Financing and liquidity no active members in the scheme.
As at the end of 2012, the Group had the following drawn term over one year to maturity funding in place: Overseas net pension liabilities increased to 50.2 million 2011 44.0 million m reecting a lower discount rate in Germany.
The non-UK schemes are Euro denominated bank loan maturing March 2015 145.4 primarily traditional German unfunded on balance sheet arrangements.
US private placements 56.9 Less: Associated currency hedges and costs 8.0 Borrowings, cash ow and liquidity Total 194.3 The following cash ow is in the format used by management and it provides a clearer presentation of the movements in underlying net This compares to a net borrowing position of 155.8 million.
The Group borrowings than the IFRS statement: had an undrawn 60 million revolving loan facility maturing March 2015, 2012 2011 and a net cash position cash and cash equivalents less short term audited audited overdrafts and factoring debt of 32.9 million.
m m Underlying operating profit In arriving at the Groups net borrowings, 20.4 million of non-recourse before joint ventures 104.1 91.6 off balance sheet factoring has been added back as a special item.
Movement in working capital 1.3 5.0 Excluding this adjustment net borrowings would have been 135.4 million.
Depreciation and amortisation This factoring facility expired at the end of December 2012 and settled underlying 18.4 18.8 over January and February 2013 though, as this is adjusted back into Capital expenditure net 38.1 21.9 net borrowings, its termination has no impact on the Groups stated Interest paid net 11.3 15.2 net borrowings.
Tax paid 18.8 19.9 Pension funding in excess of Underlying net borrowings to EBITDA, the Groups key leverage metric, IAS19 charge 17.3 11.0 was 1.2 at the end of 2012 2011 1.2.
Minority interest and joint venture cash ows 3.2 6.3 Operating cash ow 38.9 43.7 David Blackwood Cash impact of restructuring 11.4 6.2 Chief Financial officer Acquisitions and disposals net 353.8 14 March 2013 Acquisition costs 0.4 4.4 Dividends paid 15.3 8.4 Net proceeds on issue of shares 216.9 Exchange other 3.3 11.3 Movement in underlying borrowings 8.5 100.9 Closing underlying net borrowings 155.8 164.3 EBITDA management: Operating profit inc joint ventures 109.0 96.4 Depreciation continuing 18.4 18.8 Total management EBITDA 127.4 115.2 Includes the release of collateral held against a guarantee that was treated as a working capital outow in 2011.
2011 includes 8.1 million EBITDA from the disposed Pharma business.
